Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.
Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.
The safety label for the prescription sleep aid Ambien (zolpidem tartrate) has been updated to include a new warning for severe injuries, the Food and Drug Administration (FDA) announced. “Zolpidem can cause drowsiness and a decreased level of consciousness, which may lead to falls and consequently to severe injuries,” the new warning states. “Severe injuries such as hip fractures and intracranial hemorrhage have been reported.” A 2012 study linked the commonly prescribed sleeping pill to a greatly increased risk of falls in hospital patients. The Mayo Clinic study of more than 16,000 hospitalized patients found that the fall rate among ... Read More
An experimental cholesterol-lowering drug from a new class of medications focused on taking a bite out of the billion-dollar statin market has outperformed Zetia, the most widely used alternative to statins on the market, according to a clinical trial presented at the American Heart Association annual meeting. Alirocumab drove down LDL, or bad, cholesterol levels in study participants by 45 percent, compared to just 14.6 percent in patients who were treated with Zetia. The main drawback is that alirocumab is administered by injection once every two weeks, while Zetia and statins are take by mouth in the form of a pill. ... Read More
Merck & Co’s cholesterol drug Zetia lowered the risk of heart attacks and strokes in high-risk patients when used with statin therapy, according to a near-decade-long study. It has long been known that statins, such as top selling Lipitor, can lower cholesterol levels and reduce the risk of heart attacks, strokes and death. But there have been few indications until now that Zetia, which lowers cholesterol in a different way, offers any benefit. The research is reassuring on some counts. Sales of Zetia and Vytorin, a combination of Zetia and the statin simvastatin, dropped since 2008 when smaller studies raised ... Read More
Long-term antiplatelet therapy with another blood thinning therapy has been shown to reduce the risk of heart attacks and the formation of blood clots in stents, but patients were at an increased risk of dying compared to patients on shorter therapy regimes, the Food and Drug Administration (FDA) announced in a Safety Advisory. The announcement is based on data from a clinical trial that compared long-term antiplatelet therapy of 30 months to patients on 12 months of therapy with either Plavix (clopidogrel) or Effient (prasugrel) in patients following implantation of drug-eluting coronary stents. The patients were also given dual antiplatelet ... Read More
Type 2 diabetes can be prevented or even reversed with simple lifestyle changes, according to Dr. Eberhard Standl, a diabetes expert and spokesman for the European Society of Cardiology (ESC). Type 2 diabetes has grown in epidemic proportions, with 400 million diabetics and another 400 million pre-diabetics around the world. The chronic disease contributes to serious health concerns including heart disease, kidney disease, dementia, amputations due to neuropathy, some forms of cancer, and blindness. The disease contributed to an estimated 5 million deaths in 2014 alone. Once known as adult-onset diabetes, type 2 diabetes now affects as many as 80,000 ... Read More
Joelle Kendle is struggling with whether to fill the prescription her doctor has given her for Risperdal for her 6-year-old son, Matthias. He is already taking the stimulant Adderall for attention deficit hyperactivity disorder (ADHD), but it barely controls his outbursts. Joelle is concerned about Risperdal side effects, and rightfully so. The drug has been associated with weight gain and diabetes. More recent studies have linked the drug to gynecomastia, a condition in which boys grow breasts. Risperdal, known generically as risperidone, is an antipsychotic medication that is approved in the United States to treat adults and children with schizophrenia, ... Read More
Younger women who have an intrauterine device, or IUD, are at greater risk of the device expelling and of experiencing adverse effects than older women, according to a study published by the American College of Obstetrics & Gynecology. IUD expulsion is when the device migrates from its intended position in the cervix. The expulsion can either be complete or incomplete. Complete expulsions occur when the device comes out of the uterus and into the vagina. A partial expulsion is when the device is pushed only partly out. In both cases, a woman is at risk of becoming pregnant or experiencing even ... Read More
A three-judge panel has found that failure-to-warn claims against makers of generic versions of the heartburn drug Reglan could move forward because the companies failed to update their warning labels when the brand name product’s label was changed to include new side effect warnings. The ruling affects a large number of the roughly 650 lawsuits consolidated in Middlesex County, where they were transferred from Atlantic County last month. The panel of judges wrestled with the 2011 ruling in Pliva v. Mensing that state tort claims against makers of generic drugs alleging inadequate warnings should be overridden by federal law, which ... Read More
A Florida federal jury determined that medical device maker Boston Scientific should pay $26.7 million to four women who claim they were injured by the company’s transvaginal mesh. The jury found Boston Scientific negligent in manufacturing the Pinnacle Pelvic Floor Repair Kit, a type of surgical mesh that is used to treat common pelvic floor disorders such as pelvic organ prolapse and stress urinary incontinence. Jurors found that the device was defective at the time of its sale because it didn’t meet reasonable expectations of its intended users, and that the benefits of the device were overshadowed by the risks, ... Read More
The number of lawsuits against Pfizer, the maker of the erectile dysfunction drug Viagra, are mounting after a recent scientific study linked use of the drug with an increased risk of melanoma, the deadliest form of skin cancer. The study, published in June by JAMA Internal Medicine, reported that Viagra users were 84 percent more likely to develop melanoma over a 10-year period. Even men who had stopped using Viagra were at increased risk compared to men who had never used the drug. The study, which involved 26,000 men who had used Viagra, was conducted by researchers with Harvard Medical ... Read More